Predictive nomogram using multimodal ultrasonographic features for axillary lymph node metastasis in early‑stage invasive breast cancer

Yao,Jiejie; Zhou,Wei; Zhu,Ying; Zhou,Jianqiao; Chen,Xiaosong; Zhan,Weiwei

doi:10.3892/ol.2024.14228

Predictive nomogram using multimodal ultrasonographic features for axillary lymph node metastasis in early‑stage invasive breast cancer

Authors:
- Jiejie Yao
- Wei Zhou
- Ying Zhu
- Jianqiao Zhou
- Xiaosong Chen
- Weiwei Zhan
View Affiliations

Affiliations: Department of Ultrasound, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, P.R. China, Comprehensive Breast Health Center, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, P.R. China
Published online on: January 11, 2024 https://doi.org/10.3892/ol.2024.14228
Article Number: 95
Copyright: © Yao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Axillary lymph node (ALN) status is a key prognostic factor in patients with early‑stage invasive breast cancer (IBC). The present study aimed to develop and validate a nomogram based on multimodal ultrasonographic (MMUS) features for early prediction of axillary lymph node metastasis (ALNM). A total of 342 patients with early‑stage IBC (240 in the training cohort and 102 in the validation cohort) who underwent preoperative conventional ultrasound (US), strain elastography, shear wave elastography and contrast‑enhanced US examination were included between August 2021 and March 2022. Pathological ALN status was used as the reference standard. The clinicopathological factors and MMUS features were analyzed with uni‑ and multivariate logistic regression to construct a clinicopathological and conventional US model and a MMUS‑based nomogram. The MMUS nomogram was validated with respect to discrimination, calibration, reclassification and clinical usefulness. US features of tumor size, echogenicity, stiff rim sign, perfusion defect, radial vessel and US Breast Imaging Reporting and Data System category 5 were independent risk predictors for ALNM. MMUS nomogram based on these factors demonstrated an improved calibration and favorable performance [area under the receiver operator characteristic curve (AUC), 0.927 and 0.922 in the training and validation cohorts, respectively] compared with the clinicopathological model (AUC, 0.681 and 0.670, respectively), US‑depicted ALN status (AUC, 0.710 and 0.716, respectively) and the conventional US model (AUC, 0.867 and 0.894, respectively). MMUS nomogram improved the reclassification ability of the conventional US model for ALNM prediction (net reclassification improvement, 0.296 and 0.288 in the training and validation cohorts, respectively; both P<0.001). Taken together, the findings of the present study suggested that the MMUS nomogram may be a promising, non‑invasive and reliable approach for predicting ALNM.

View Figures

View References

1	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
2	Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, et al: Effect of axillary dissection vs. no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (alliance) randomized clinical trial. JAMA. 318:918–926. 2017. View Article : Google Scholar : PubMed/NCBI
3	Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL and Giuliano AE: Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 35:561–564. 2017. View Article : Google Scholar : PubMed/NCBI
4	Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, et al: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol. 13:491–500. 2006. View Article : Google Scholar : PubMed/NCBI
5	Manca G, Rubello D, Tardelli E, Giammarile F, Mazzarri S, Boni G, Chondrogiannis S, Marzola MC, Chiacchio S, Ghilli M, et al: Sentinel lymph node biopsy in breast cancer: Indications, contraindications, and controversies. Clin Nucl Med. 41:126–133. 2016. View Article : Google Scholar : PubMed/NCBI
6	Zhang YN, Wang CJ, Xu Y, Zhu QL, Zhou YD, Zhang J, Mao F, Jiang YX and Sun Q: Sensitivity, specificity and accuracy of ultrasound in diagnosis of breast cancer metastasis to the axillary lymph nodes in Chinese patients. Ultrasound Med Biol. 41:1835–1841. 2015. View Article : Google Scholar : PubMed/NCBI
7	Hotton J, Salleron J, Henrot P, Buhler J, Leufflen L, Rauch P and Marchal F: Pre-operative axillary ultrasound with fine-needle aspiration cytology performance and predictive factors of false negatives in axillary lymph node involvement in early breast cancer. Breast Cancer Res Treat. 183:639–647. 2020. View Article : Google Scholar : PubMed/NCBI
8	Yu FH, Wang JX, Ye XH, Deng J, Hang J and Yang B: Ultrasound-based radiomics nomogram: A potential biomarker to predict axillary lymph node metastasis in early-stage invasive breast cancer. Eur J Radiol. 119:1086582019. View Article : Google Scholar : PubMed/NCBI
9	Qiu X, Jiang Y, Zhao Q, Yan C, Huang M and Jiang T: Could ultrasound-based radiomics noninvasively predict axillary lymph node metastasis in breast cancer? J Ultrasound Med. 39:1897–1905. 2020. View Article : Google Scholar : PubMed/NCBI
10	Jiang M, Li CL, Luo XM, Chuan ZR, Chen RX, Tang SC, Lv WZ, Cui XW and Dietrich CF: Radiomics model based on shear-wave elastography in the assessment of axillary lymph node status in early-stage breast cancer. Eur Radiol. 32:2313–2325. 2022. View Article : Google Scholar : PubMed/NCBI
11	Lee S, Jung Y and Bae Y: Clinical application of a color map pattern on shear-wave elastography for invasive breast cancer. Surg Oncol. 25:44–48. 2016. View Article : Google Scholar : PubMed/NCBI
12	Tozaki M and Fukuma E: Pattern classification of ShearWave™ elastography images for differential diagnosis between benign and malignant solid breast masses. Acta Radiol. 52:1069–1075. 2011. View Article : Google Scholar : PubMed/NCBI
13	Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, Baker L, Jordan L, Rauchhaus P and Thompson A: Invasive breast cancer: Relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology. 263:673–677. 2012. View Article : Google Scholar : PubMed/NCBI
14	Huang R, Lin Z, Dou H, Wang J, Miao J, Zhou G, Jia X, Xu W, Mei Z, Dong Y, et al: AW3M: An auto-weighting and recovery framework for breast cancer diagnosis using multi-modal ultrasound. Med Image Anal. 72:1021372021. View Article : Google Scholar : PubMed/NCBI
15	Zheng X, Yao Z, Huang Y, Yu Y, Wang Y, Liu Y, Mao R, Li F, Xiao Y, Wang Y, et al: Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. J Nat Commun. 11:12362020. View Article : Google Scholar : PubMed/NCBI
16	Guo X, Liu Z, Sun C, Zhang L, Wang Y, Li Z, Shi J, Wu T, Cui H, Zhang J, et al: Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer. EBioMedicine. 60:1030182020. View Article : Google Scholar : PubMed/NCBI
17	Liu D, Wu J, Lin C, Ding S, Lu S, Fang Y, Huang J, Hong J, Gao W, Zhu S, et al: The comparative safety of epirubicin and cyclophosphamide versus docetaxel and cyclophosphamide in lymph node-negative, HR-positive, HER2-negative breast cancer (ELEGANT): A randomized trial. Cancers (Basel). 14:32212022. View Article : Google Scholar : PubMed/NCBI
18	Collins GS, Reitsma JB, Altman DG and Moons KG: Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. Br J Surg. 102:148–158. 2015. View Article : Google Scholar : PubMed/NCBI
19	Penault-Llorca F, André F, Sagan C, Lacroix-Triki M, Denoux Y, Verriele V, Jacquemier J, Baranzelli MC, Bibeau F, Antoine M, et al: Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer. J Clin Oncol. 27:2809–2815. 2009. View Article : Google Scholar : PubMed/NCBI
20	Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B and Senn HJ; Panel Members, : Tailoring therapies-improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015. Ann Oncol. 26:1533–1546. 2015. View Article : Google Scholar : PubMed/NCBI
21	Mercado CL: BI-RADS update. Radiol Clin North Am. 52:481–487. 2014. View Article : Google Scholar : PubMed/NCBI
22	Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL Jr and Hunt KK: Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: In vitro sonographic study. AJR Am J Roentgenol. 191:646–652. 2008. View Article : Google Scholar : PubMed/NCBI
23	Koelliker SL, Chung MA, Mainiero MB, Steinhoff MM and Cady B: Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer-correlation with primary tumor size. Radiology. 246:81–89. 2008. View Article : Google Scholar : PubMed/NCBI
24	Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, Yamakawa M and Matsumura T: Breast disease: Clinical application of US elastography for diagnosis. Radiology. 239:341–350. 2006. View Article : Google Scholar : PubMed/NCBI
25	Zhou J, Zhan W, Chang C, Zhang X, Jia Y, Dong Y, Zhou C, Sun J and Grant EG: Breast lesions: Evaluation with shear wave elastography, with special emphasis on the ‘stiff rim’ sign. Radiology. 272:63–72. 2014. View Article : Google Scholar : PubMed/NCBI
26	Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, Bertolotto M, Calliada F, Clevert DA, Cosgrove D, et al: The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: Update 2017 (long version). Ultraschall Med. 39:e2–e44. 2018. View Article : Google Scholar : PubMed/NCBI
27	Li H, Jun Z, Zhi-Cheng G and Xiang Q: Factors that affect the false negative rate of sentinel lymph node mapping with methylene blue dye alone in breast cancer. J Int Med Res. 47:4841–4853. 2019. View Article : Google Scholar : PubMed/NCBI
28	Pesek S, Ashikaga T, Krag LE and Krag D: The false-negative rate of sentinel node biopsy in patients with breast cancer: A meta-analysis. World J Surg. 36:2239–2251. 2012. View Article : Google Scholar : PubMed/NCBI
29	Fang J, Zhao W, Li Q, Zhang B, Pu C and Wang H: Correlation analysis of conventional ultrasound characteristics and strain elastography with ki-67 status in breast cancer. Ultrasound Med Biol. 46:2972–2978. 2020. View Article : Google Scholar : PubMed/NCBI
30	Wan CF, Du J, Fang H, Li FH, Zhu JS and Liu Q: Enhancement patterns and parameters of breast cancers at contrast-enhanced US: Correlation with prognostic factors. Radiology. 262:450–459. 2012. View Article : Google Scholar : PubMed/NCBI
31	Zhu AQ, Li XL, An LW, Guo LH, Fu HJ, Sun LP and Xu HX: Predicting axillary lymph node metastasis in patients with breast invasive ductal carcinoma with negative axillary ultrasound results using conventional ultrasound and contrast-enhanced ultrasound. J Ultrasound Med. 39:2059–2070. 2020. View Article : Google Scholar : PubMed/NCBI
32	Bevilacqua JL, Kattan MW, Fey JV, Cody HS III, Borgen PI and Van Zee KJ: Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 25:3670–3679. 2007. View Article : Google Scholar : PubMed/NCBI
33	Yoshihara E, Smeets A, Laenen A, Reynders A, Soens J, Van Ongeval C, Moerman P, Paridaens R, Wildiers H, Neven P and Christiaens MR: Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast. 22:357–361. 2013. View Article : Google Scholar : PubMed/NCBI
34	Xiong J, Zuo W, Wu Y, Wang X, Li W, Wang Q, Zhou H, Xie M and Qin X: Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases. BMC Cancer. 22:11552022. View Article : Google Scholar : PubMed/NCBI
35	Yu Y, Tan Y, Xie C, Hu Q, Ouyang J, Chen Y, Gu Y, Li A, Lu N, He Z, et al: Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw Open. 3:e20280862020. View Article : Google Scholar : PubMed/NCBI
36	Dong Y, Feng Q, Yang W, Lu Z, Deng C, Zhang L, Lian Z, Liu J, Luo X, Pei S, et al: Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol. 28:582–591. 2018. View Article : Google Scholar : PubMed/NCBI
37	Fujii T, Yajima R, Tatsuki H, Suto T, Morita H, Tsutsumi S and Kuwano H: Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer. Anticancer Res. 35:3581–3584. 2015.PubMed/NCBI
38	Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M and Kosma VM: Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol. 156:529–536. 2000. View Article : Google Scholar : PubMed/NCBI
39	Bae MS, Shin SU, Song SE, Ryu HS, Han W and Moon WK: Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1-T2N0 breast cancer. Acta Radiol. 59:402–408. 2018. View Article : Google Scholar : PubMed/NCBI
40	Sheng DL, Shen XG, Shi ZT, Chang C and Li JW: Survival outcome assessment for triple-negative breast cancer: A nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics. Eur Radiol. 32:6575–6587. 2022. View Article : Google Scholar : PubMed/NCBI
41	Zhang H, Dong Y, Jia X, Zhang J, Li Z, Chuan Z, Xu Y, Hu B, Huang Y, Chang C, et al: Comprehensive risk system based on shear wave elastography and BI-RADS categories in assessing axillary lymph node metastasis of invasive breast cancer-A multi-center study. Front Oncol. 12:8309102022. View Article : Google Scholar : PubMed/NCBI
42	Evans A, Rauchhaus P, Whelehan P, Thomson K, Purdie CA, Jordan LB, Michie CO, Thompson A and Vinnicombe S: Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer? Breast Cancer Res Treat. 143:153–157. 2014. View Article : Google Scholar : PubMed/NCBI
43	Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O and Kudo S: Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: Correlation of MR findings with histologic features and expression of growth factors. Radiology. 217:841–848. 2000. View Article : Google Scholar : PubMed/NCBI
44	Yao J, Zhou W, Xu S, Jia X, Zhou J, Chen X and Zhan W: Machine learning-based breast tumor ultrasound radiomics for pre-operative prediction of axillary sentinel lymph node metastasis burden in early-stage invasive breast cancer. Ultrasound Med Biol. 50:229–236. 2024. View Article : Google Scholar : PubMed/NCBI
45	Yang K, Kim H, Choi DH, Park W, Noh JM and Cho WK: Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer. Radiat Oncol. 15:162020. View Article : Google Scholar : PubMed/NCBI
46	van Nijnatten TJA, Ploumen EH, Schipper RJ, Goorts B, Andriessen EH, Vanwetswinkel S, Schavemaker M, Nelemans P, de Vries B, Beets-Tan RGH, et al: Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients. Eur J Radiol. 85:2288–2294. 2016. View Article : Google Scholar : PubMed/NCBI
47	Samiei S, van Nijnatten TJA, van Beek HC, Polak MPJ, Maaskant-Braat AJG, Heuts EM, van Kuijk SMJ, Schipper RJ, Lobbes MBI and Smidt ML: Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients. Sci Rep. 9:174762019. View Article : Google Scholar : PubMed/NCBI